Kiely John
Director at AMRX
- Sold, on record
- $1.7M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 13, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AMRXAmneal Pharmaceuticals, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice AMRXNoticeNov 22, 2024 2024
Filed to sell 17,058 shares ($142k)
Kiely John, Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale AMRXNo planNov 22, 2024 same day
Sold 17,058 shares at $8.38 ($143k)
Kiely John, Director
No 10b5-1 planSold 6% of holdings ($2.4M position)267,175 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale AMRXNo planMay 12, 2025 +171 days
Sold 50,000 shares at $7.59 ($380k)
Kiely John, Director
No 10b5-1 planSold 16.3% of holdings ($2.3M position)257,433 shares leftFiling
- 4 Form 4 sale AMRXNo planAug 27, 2025 +107 days
Sold 32,000 shares at $9.23 ($295k)
Kiely John, Director
No 10b5-1 planSold 12.4% of holdings ($2.4M position)225,433 shares leftFiling
- 5 Form 4 sale AMRXNo planAug 13, 2026 +351 days
Sold 50,000 shares at $17.64 ($882k)
Kiely John, Director
No 10b5-1 planSold 19.2% of holdings ($4.6M position)210,252 shares left1.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Aug 14, 2026 | AMRX | Director | Form 4 sale | 50,000 | $882k | 19.2% | No plan | SEC |
| Aug 27, 2025 | Aug 28, 2025 | AMRX | Director | Form 4 sale | 32,000 | $295k | 12.4% | No plan | SEC |
| May 12, 2025 | May 13, 2025 | AMRX | Director | Form 4 sale | 50,000 | $380k | 16.3% | No plan | SEC |
| Nov 22, 2024 | Nov 26, 2024 | AMRX | Director | Form 4 sale | 17,058 | $143k | 6.0% | No plan | SEC |
| Nov 22, 2024 | Nov 22, 2024 | AMRX | Director | Form 144 notice | 17,058 | $142k | Notice | SEC |